VETMEDIN® (pimobendan) Chewable Tablets is the only FDA-approved inodilator¹ that according to published studies, helps extend the survival time and improves quality of life in dogs with congestive heart failure (CHF).²,³ Given every 12 hours, the unique dual action of VETMEDIN dilates the blood vessels carrying blood to and from the heart—reducing the preload and afterload on the heart—while simultaneously improving contractility of the heart muscle.1 Pimobendan, the active ingredient in VETMEDIN, reduces stress on the heart while increasing cardiac output, without raising oxygen or energy consumption. VETMEDIN helps dogs engage in the daily activities they enjoy. Increasing age is a risk factor for heart disease and heart failure.⁴ According to published studies, with early diagnosis and treatment of clinical signs, you can prolong your dog’s life and improve their quality of life.²,³ Be sure to talk to your veterinarian about VETMEDIN if your dog is in heart failure to determine the proper treatment for your pet. References: 1. VETMEDIN® (pimobendan) Chewable Tablets [Freedom of Information Summary; NADA 141-273]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2007. 2. Häggström J, Boswood A, O’Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124-1135. 3. Lombard CW, Jöns O, Bussadori CM; for the VetSCOPE Study. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249-261. 4. Keene et al ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs J Vet Intern Med 2019.